CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 38 enrolled
Drug / intervention
Xenaderm +1 moredrug
Likely dose
Xenaderm 20mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00644917
NCT00644917Phase 1Completed
CompareCT.gov

Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment

Healthpoint·interventional·Posted Mar 27, 2008·Updated Jan 13, 2014

In Brief

A Phase 1 clinical trial evaluating Xenaderm and Placebo for Healthy. Completed, enrolled 38 participants.

Detailed Summary

The product is being tested to see if exposure to light causes toxic reactions on the skin.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
Countries--
Collaborators--

Timeline

Phase 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 27, 2008
Enrollment StartFeb 1, 2008
Primary CompletionFeb 1, 2008
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 18.3 years ago

Interventions

Xenadermdrug

20mg under Finn chambers

Placebodrug

20mg under Finn chambers